DEVS vs NBIX
DevvStream Corp. Common Stock (DEVS) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DEVS currently screens at market cap $13.4M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DEVS and NBIX stock pages for the full models.
Not investment advice.